NDC 80425-0227-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0227
- Requested NDC
- 80425-0227-01
- Package NDCs from labels
- 80425-0227-1, 80425-0227-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0227-1 | Ondansetron | 10 in 1 BOTTLE, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0227 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20250102_f1a0cd50-aa4f-55bc-e053-2995a90a2d3a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0227-1 | EA - Each | 80425-0227 | 6b0b97f9-0549-4145-81d9-0939a1e667a5 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron HCL | ONDANSETRON HCL | Advanced Rx of Tennessee, LLC | af735f22-6d6c-6e1f-e053-2a95a90a3532 | 2026-03-13 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Bryant Ranch Prepack | e2c0e86c-e7fc-48f9-a894-02da8761001c | 2026-03-05 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals, Inc. | 50383ef5-6e6e-63a7-e054-00144ff88e88 | 2026-03-04 | Warnings, Adverse reactions | ANDA078152 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | ef6ce203-4ae3-19c9-e053-2995a90af796 | 2026-02-27 | Warnings, Adverse reactions | ANDA078152 104894 4AF302ESOS |
| ONDANSETRON | ONDANSETRON | Direct_Rx | 90b73778-2ab5-5460-e053-2a95a90abbc1 | 2026-02-19 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | A-S Medication Solutions | 378d0963-d026-4478-8202-fbb636904a37 | 2026-02-18 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
| ONDANSETRON | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | b746d4db-43e6-4219-9e6b-f53e59581305 | 2026-02-13 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | A-S Medication Solutions | e0f69f57-aeb9-4890-85aa-e5976208e8be | 2026-02-12 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 9dff6676-e69e-779d-e053-2995a90a7c81 | 2026-01-27 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Golden State Medical Supply, Inc. | 2b9ea1fc-59a4-8189-e063-6394a90a9ae6 | 2026-01-27 | Warnings, Adverse reactions | 312086 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc. | 76666e7e-3312-6f9d-e053-2991aa0af705 | 2026-01-23 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | PD-Rx Pharmaceuticals, Inc. | 15d0a711-ef3b-4d93-8fbc-17a45f96af8a | 2026-01-20 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | PD-Rx Pharmaceuticals, Inc. | d117de5f-64e5-464c-b782-de0f07e66c8e | 2026-01-20 | Warnings, Adverse reactions | ANDA078152 312087 4AF302ESOS |
| ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 26aff90c-49ea-46ac-bbf3-c188c2b061c9 | 2026-01-14 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE | Cardinal Health 107, LLC | 30107d6f-5128-484f-b713-65244a98dc67 | 2026-01-14 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | AvPAK | 05cf8d4f-ac57-4177-e063-6394a90ae804 | 2026-01-09 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Glenmark Pharmaceuticals Inc., USA | eee5217a-eba8-463a-812d-bf3c66f0934f | 2026-01-08 | Warnings, Adverse reactions | ANDA078152 68462-158 312086 198052 312087 104894 32177a6a-8c35-4e1c-b7f5-7376b1c1316a eee5217a-eba8-463a-812d-bf3c66f0934f 4AF302ESOS NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Chartwell Governmental & Specialty RX, LLC. | 7e862601-1d8a-455b-8ce5-1a32478b309f | 2026-01-07 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Chartwell RX, LLC. | 2086bae8-7c3c-4663-93ac-c86407c524c2 | 2026-01-02 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Northwind Health Company, LLC | f76d27c5-acd4-482c-e053-6294a90a5284 | 2026-01-01 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.